RESUMO
Vitiligo is a disease characterised by the autoimmune destruction of melanocytes, manifesting as depigmentation of the skin. We present the case of a female patient with a history of breast cancer who developed vitiligo in the area of the treatment field 12 months after the end of radiotherapy. It has been reported in the literature that vitiligo can occur in patients with a history of vitiligo after radiotherapy, attributable to the Koebner phenomenon, where some treatments can induce new vitiligo lesions in the patient.
RESUMO
INTRODUCTION: The evidence supporting pharmacological heart failure treatment relies on randomized clinical trials with stringent inclusion and exclusion criteria. OBJECTIVES: Assess the eligibility of outpatients with chronic heart failure for the trials DAPA-HF, EMPEROR-reduced, and PARADIGM-HF, while exploring potential differences among study populations. METHODS: By reviewing medical records, we determined the eligibility rate for each study and evaluated the incidence of heart failure hospitalizations and all-cause mortality during this period. RESULTS: A total of 446 patients were included in the cohort. Approximately 75% would be ineligible for the trials, mainly because of their comorbidities. Ineligible patients had a higher all-cause mortality, but a similar incidence of hospitalization. CONCLUSION: Approximately 1 in 4 patients from a heart failure clinic in Medellin, Colombia would meet the eligibility criteria for the DAPA-HF, EMPEROR-reduced, and PARADIGM-HF trials. These findings highlight the need to complement randomized clinical trials with real-world data.
Assuntos
Cardiologia , Insuficiência Cardíaca , Humanos , Valsartana/uso terapêutico , Volume Sistólico , Tetrazóis/efeitos adversos , Estudos Retrospectivos , Colômbia/epidemiologia , Antagonistas de Receptores de Angiotensina/uso terapêutico , Combinação de Medicamentos , Insuficiência Cardíaca/epidemiologia , Insuficiência Cardíaca/terapiaRESUMO
BACKGROUND: Severe oral mucositis associated with cancer therapy is a frequent complication that may affect a patient's systemic condition, resulting in interruption and/or prolongation of cancer therapy. Dentoxol® is a medical solution in the form of a mouthwash that has been shown to result in statistically significant improvement in the prevention of severe oral mucositis. However, knowing the measures of the clinical significance of this therapy is important for accurate decision-making. AIM: To describe the clinical impact of Dentoxol® use in severe oral mucositis. METHODS: Clinical significance was measured using the results obtained in a randomized controlled clinical trial previously conducted by the same group of researchers. The measures of clinical significance evaluated were the absolute risk or incidence, relative risk, absolute risk reduction, relative risk reduction, number needed to treat, and odds ratio. RESULTS: The data obtained show that the impact of Dentoxol® on reducing the severity of oral mucositis has important clinical relevance. CONCLUSION: The results of this study justify the incorporation of Dentoxol® mouth rinse into clinical protocols as a complement to cancer therapy to prevent and/or treat oral mucositis secondary to radiotherapy.
RESUMO
Atypical Fibroxanthoma is an unusual dermal mesenchymal tumor. It especially affects older adults and occurs in areas of sun exposure. We report a 75 years old male with a history of sun exposure without using a hat presenting with a scalp nodule. An incisional biopsy showed an atypical fibroxantoma. In a new surgical procedure, the tumor was completely excised. The tumor relapsed in two occasions after subsequent excisions and the patient was treated with adjuvant radiotherapy avoiding new relapses.
Assuntos
Humanos , Masculino , Idoso , Couro Cabeludo/patologia , Neoplasias Cutâneas/patologia , Xantomatose/patologia , Neoplasias Cutâneas/radioterapia , Biópsia , Xantomatose/radioterapia , Resultado do TratamentoRESUMO
Atypical Fibroxanthoma is an unusual dermal mesenchymal tumor. It especially affects older adults and occurs in areas of sun exposure. We report a 75 years old male with a history of sun exposure without using a hat presenting with a scalp nodule. An incisional biopsy showed an atypical fibroxantoma. In a new surgical procedure, the tumor was completely excised. The tumor relapsed in two occasions after subsequent excisions and the patient was treated with adjuvant radiotherapy avoiding new relapses.
Assuntos
Couro Cabeludo/patologia , Neoplasias Cutâneas/patologia , Xantomatose/patologia , Idoso , Biópsia , Humanos , Masculino , Neoplasias Cutâneas/radioterapia , Resultado do Tratamento , Xantomatose/radioterapiaRESUMO
El metotrexato (MTX) es un agente anti folato con actividad antineoplásica e inmunosupresora que ha alcanzado gran aceptación y uso debido a su eficacia en distintos desórdenes reumatológicos. Sin embargo, tiene el potencial para causar complicaciones serias y, a veces, mortales, principalmente hematológicas, hepáticas o pulmonares. Los factores de riesgo para el desarrollo de pancitopenia incluyen edad avanzada, alteración de la función renal, niveles bajos de ácido fólico y uso concomitante de otros fármacos que modifiquen el metabolismo del folato. Presentamos un caso de pancitopenia severa y estomatitis, secundaria a una dosis estándar de MTX, en una paciente de 53 años de edad, con Artritis Reumatoídea (AR) de 10 años de evolución y enfermedad renal crónica en hemodiálisis trisemanal. Es muy importante prestar atención a los factores de riesgo asociados a la aparición de efectos adversos antes de iniciar terapia con MTX en pacientes reumatológicos. Además, los pacientes con MTX deben ser monitorizados durante su tratamiento para identificar efectos adversos hematológicos severos, como la pancitopenia.
Methotrexate (MTX) is an agent for anti-folate with antineoplastic activity and immunosuppressive that has achieved wide acceptance and use due to its efficacy in various rheumatologic disorders. However, it has the potential to cause complications serious and sometimes deadly, primarily hematologic, hepatic or pulmonary. The factors of risk for the development of pancytopenia include advanced age, renal function, low levels of folic acid and concomitant use of other drugs that alter the metabolism of folate. We present a case of severe pancytopenia and stomatitis, secondary to a standard dose of MTX in patient of 53 years, with rheumatoid arthritis (RA) of 10 years of evolution and chronic kidney disease on hemodialysis immediately. It is very important to pay attention to the risk factors associated with the occurrence of adverse effects, before initiating therapy with MTX in rheumatologic patients. In addition MTX patients should be monitored during treatment to identify severe haematological adverse effects such as pancytopenia.
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Antirreumáticos/efeitos adversos , Artrite Reumatoide/tratamento farmacológico , Metotrexato/efeitos adversos , Pancitopenia/induzido quimicamente , Estomatite/induzido quimicamenteRESUMO
BACKGROUND: The Chilean Ministry of Health developed a healthy lifestyles intervention directed to adults with overweight and cardiovascular risk factors, called "Program on Healthy Eating and Physical Activity" (PASAF). AIM: To evaluate the impact of PASAF on nutritional status and metabolic parameters. PATIENTS AND METHODS: We analyzed databases from three primary care centers belonging to a municipality of Metropolitan Santiago. We selected adults enrolled in the PASAF during three years (2007-2009). The program lasted four months and included an assessment of anthropometric and metabolic parameters at baseline and at the end, eight workshops with a nutritionist, seven with a psychologist and 32 sessions of physical activity. RESULT: We evaluated 526 subjects aged ≥18 years (93% females), of whom 85.6% attended the last appointment for assessment. Analyzing available data, attendance to workshops was <50% of the scheduled sessions. Weight, body mass index and waist circumference decreased significantly (median: -1.4 kg, -0.6 kg/m² and -3 cm, respectively). The median weight loss was 1.8% of initial weight and 17.1% of participants experienced a decrease ≥5% of their initial weight. There were significant improvements in lipid levels and blood pressure among participants with lower initial excess weight. A reduction in fasting blood glucose was observed only among subjects who lost ≥5% of their initial weight. CONCLUSIONS: The PASAF modestly reduced nutritional parameters. Correction of metabolic parameters was especially effective in less obese subjects. The attendance to workshops was low.
Assuntos
Promoção da Saúde/métodos , Síndrome Metabólica/reabilitação , Obesidade/reabilitação , Adulto , Índice de Massa Corporal , Chile , Feminino , Humanos , Estilo de Vida , Estudos Longitudinais , Masculino , Síndrome Metabólica/metabolismo , Pessoa de Meia-Idade , Estado Nutricional , Obesidade/metabolismo , Cooperação do Paciente , Avaliação de Programas e Projetos de Saúde , Redução de PesoRESUMO
Background: The Chilean Ministry of Health developed a healthy lifestyles intervention directed to adults with overweight and cardiovascular risk factors, called "Program on Healthy Eating and Physical Activity" (PASAF). Aim: To evaluate the impact of PASAF on nutritional status and metabolic parameters. Patients and Methods: We analyzed databases from three primary care centers belonging to a municipality of Metropolitan Santiago. We selected adults enrolled in the PASAF during three years (2007-2009). The program lasted four months and included an assessment of anthropometric and metabolic parameters at baseline and at the end, eight workshops with a nutritionist, seven with a psychologist and 32 sessions of physical activity. Result: We evaluated 526 subjects aged ≥ 18 years (93% females), of whom 85.6% attended the last appointment for assessment. Analyzing available data, attendance to workshops was < 50% of the scheduled sessions. Weight, body mass index and waist circumference decreased significantly (median: -1.4 kg, -0.6 kg/m² and -3 cm, respectively). The median weight loss was 1.8% of initial weight and 17.1% of participants experienced a decrease ≥ 5% of their initial weight. There were significant improvements in lipid levels and blood pressure among participants with lower initial excess weight. A reduction in fasting blood glucose was observed only among subjects who lost ≥ 5% of their initial weight. Conclusions: The PASAF modestly reduced nutritional parameters. Correction of metabolic parameters was especially effective in less obese subjects. The attendance to workshops was low.
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Promoção da Saúde/métodos , Síndrome Metabólica/reabilitação , Obesidade/reabilitação , Índice de Massa Corporal , Chile , Estilo de Vida , Estudos Longitudinais , Síndrome Metabólica/metabolismo , Estado Nutricional , Obesidade/metabolismo , Cooperação do Paciente , Avaliação de Programas e Projetos de Saúde , Redução de PesoRESUMO
BACKGROUND/AIMS: To measure skeletal muscle lipid infiltration, its association with insulin resistance (IR) lean mass and function, in Chilean men differing in age and body composition. Our hypothesis was that muscle lipid accumulation would be higher among older and heavier individuals and this would deteriorate insulin sensitivity (IS) and decrease muscle mass and function, both features of the ageing process. METHODS: Healthy men (38 < 55 and 18 > 65 years), underwent anthropometric measurements, body composition assessment through radiologic densitometry, Nuclear Magnetic Resonance spectroscopy at the tibialis anterioris muscle to measure intra (IMCL) and extramyocellular lipids (EMCL), quadriceps and handgrip strength, 12 minute walking distance and serum biochemistry (haemoglobin, lipoproteins, creatinine, ultrasensitive C Reactive Protein, fasting and post glucose insulin and glucose concentrations, to assess IS). Physical activity was estimated by actigraphy. RESULTS: 23 men were eutrophic, 26 were overweight and 7 were obese and mostly sedentary, independent of age. Both IMCL and EMCL were higher in overweight/ obese men. Abdominal fat was negatively associated with IS and positively correlated with muscle lipid accretion (both IMCL and EMCL), but not with age. As expected, older individuals had lower muscle mass and strength, but not more adipose tissue nor intramyocellular lipids, yet were more glucose intolerant. CONCLUSIONS: central obesity was associated with IMCL and EMCL infiltration and IR. This type of lipid accretion was not related with ageing nor age-related sarcopenia. Older individuals were more glucose intolerant, which was explained by a decrease of insulin secretion more than adiposity-related IR.
Introducción/Objetivos: medir la infiltracion grasa en el musculo esqueletico, su asociacion con resistencia a la insulina (RI) y con masa y funcion muscular, en hombres chilenos de diferente edad y composicion corporal. Nuestra hipotesis era que habria mas acumulacion de grasa en el tejido muscular entre las personas de mayor edad y peso, lo cual deterioraria la sensibilidad a la insulina (SI) y afectaria negativamente la masa y la funcion muscular, ambas caracteristicas del proceso de envejecimiento. Métodos: se estudiaron hombres sanos (38 < 55 anos y 18 > 65 anos), que fueron sometidos a mediciones antropometricas, evaluacion de la composicion corporal mediante densitometria radiologica (DEXA), espectroscopia de resonancia nuclear magnetica en el musculo tibial anterior para medir lipidos intra (LIM) y extramiocelulares (LEM), fuerza de mano y cuadriceps, test de 12 minutos y bioquimica serica (glicemia, hemoglobina, lipoproteinas, creatinina y proteina C reactiva ultrasensible en ayunas, ademas de glucosa e insulina post carga de glucosa para evaluar SI). La actividad fisica se estimo mediante actigrafia. Resultados: 23 hombres eran eutroficos, 26 tenian sobrepeso y 7 eran obesos, todos eran sedentarios segun el registro actigrafico, independiente de la edad. Tanto LIM como LEM resultaron mas altos entre los hombres con sobrepeso / obesidad. La grasa abdominal se asocio negativamente con la SI y se correlaciono positivamente con la acumulacion de grasa en el musculo (tanto LIM como LEM), pero no con la edad. Como era de esperar, las personas mayores tenian menor masa magra y fuerza, pero no mas tejido adiposo ni lipidos intramiocelulares, aunque eran mas intolerantes a la glucosa. Conclusiones: La obesidad central se asocio con infiltracion de grasa intramuscular y con RI. Esta distribucion adiposa no se relaciono con edad ni con sarcopenia asociada al envejecimiento. Las personas mayores resultaron mas intolerantes a la glucosa, explicable por una disminucion de la secrecion de insulina mas que por RI relacionada con mayor adiposidad.